OHE Expert Profile
Adrian Towse
Director Emeritus and Senior Research Fellow
Adrian is an economist, focussing on the use of value–based pricing in drug/ vaccine reimbursement and the economics of innovation. He is a Visiting Professor in Practice at the London School of Economics.
Adrian’s current research interests include incentives for new drugs and vaccines to tackle Antimicrobial Resistance; the use of ‘risk– sharing’ arrangements between health care payers and pharmaceutical companies, measuring novel elements of value and the use of value–based pricing; the economics of stratified medicine for health care payers and the pharmaceutical industry; and economic issues that affect both R&D for and access to treatments for diseases prevalent in the low and middle income countries.
Latest Publications

A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance

Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechanism

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies
Read more
© photoguns

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?
Read more
© NCI/Unsplash

It Takes Two to Tango: When do Conditional Reimbursement Risk-Sharing Schemes Work for Both Parties?

Similar Experts